2019
DOI: 10.3389/fneur.2019.01207
|View full text |Cite
|
Sign up to set email alerts
|

Qualitative Assessment of Longitudinal Changes in Phenocopy Frontotemporal Dementia

Abstract: Phenocopy frontotemporal dementia (phFTD) shares core characteristics with behavioral variant frontotemporal dementia (bvFTD), yet without associated cognitive deficits and brain abnormalities on conventional magnetic resonance imaging (MRI), and without progression. Using advanced MRI techniques, we previously observed subtle structural and functional brain changes in phFTD similar to bvFTD. The aim of the current study was to follow these as well as cognition in phFTD over time, by means of a descriptive cas… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 48 publications
0
3
0
Order By: Relevance
“…Their 2019 case series attempts to address this with the description of 6 genetically screened patients with phenocopy whose gray matter volumes were noted to be in between those of the comparator bvFTD and healthy control groups and unchanged at repeat assessment close to 3 years later. 47 Although these studies are limited by the small sample sizes, the rigorous selection criteria, which included genetic testing, enhance the validity of the results. The findings are the first to provide evidence of underlying neuropathological changes that may account for the phenocopy presentation.…”
Section: Imagingmentioning
confidence: 99%
See 1 more Smart Citation
“…Their 2019 case series attempts to address this with the description of 6 genetically screened patients with phenocopy whose gray matter volumes were noted to be in between those of the comparator bvFTD and healthy control groups and unchanged at repeat assessment close to 3 years later. 47 Although these studies are limited by the small sample sizes, the rigorous selection criteria, which included genetic testing, enhance the validity of the results. The findings are the first to provide evidence of underlying neuropathological changes that may account for the phenocopy presentation.…”
Section: Imagingmentioning
confidence: 99%
“…Their 2019 case series attempts to address this with the description of 6 genetically screened patients with phenocopy whose gray matter volumes were noted to be in between those of the comparator bvFTD and healthy control groups and unchanged at repeat assessment close to 3 years later. 47…”
Section: Reviewmentioning
confidence: 99%
“…Occasionally, patients with bvFTD phenocopy syndromes and slowly progressive bvFTD, respectively, may show a C9ORF72 hexanucleotide expansion (Khan et al 2012;Devenney et al 2018). Given the comparatively subtle, slow, or non-progressive clinical, neuropsychological, and neuroimaging changes in FTD phenocopy syndrome, a common disease spectrum for the bvFTD phenocopy syndrome and the bvFTD has been proposed (Meijboom et al 2019).…”
Section: Determining Disease Onset and Progressionmentioning
confidence: 99%